EMA – The Committee for Medicinal Products for Human Use (CHMP) for the medicinal product Nilemdo adopted a new indication as follows: Cardiovascular disease
21/03/2024
Leggi
Breaking news
EMA – The Committee for Medicinal Products for Human Use (CHMP) recommended granting a marketing authorisation for Awiqli (insulin icodec) for the treatment of diabetes mellitus in adults
21/03/2024
Leggi
Non-alcoholic fatty liver disease and gestational diabetes mellitus: a bidirectional two-sample mendelian randomization study
Zhou BG, Xia JL, Jiang X, et al.
BMC Endocr Disord. 2024;24(1):40.
Leggi
Efficacy and safety of tirzepatide in overweight and obese adult patients with type 1 diabetes
Garg SK, Akturk HK, Kaur G, et al.
Diabetes Technol Ther. Pub. online 21 Mar 2024.
Leggi
The potential for improved outcomes in the prevention and therapy of diabetic kidney disease through ‘stacking’ of drugs from different classes
Bell DSH, Jerkins T
Diabetes Obes Metab. Pub. online 22 Mar 2024.
Leggi
Associations between hypoglycemia awareness status and symptoms of hypoglycemia among adults with type 1 or insulin-treated type 2 diabetes using the Hypo-METRICS smartphone application
Martine-Edith G, Zaremba N, Divilly P, et al.
Diabetes Technol Ther. Pub. online 21 Mar 2024.
Leggi
Prevalence of distal symmetrical polyneuropathy by diabetes prevention program treatment group, diabetes status, duration of diabetes, and cumulative glycemic exposure
Lee CG, Ciarleglio A, Edelstein SL, et al.
Diabetes Care. 2024;dc232009.
Leggi
Treatment Intensification following Glucagon-Like Peptide-1 Receptor Agonist in Type 2 Diabetes: Comparative Effectiveness Analyses Between Free vs. Fixed combination of GLP-1 RA and Basal Insulin. RESTORE-G Real-World Study
Candido R, Nicolucci A, Larosa M, Rossi MC, Napoli R on behalf of the RESTORE-G (Retrospective analysis on the therapeutic approches after GLP1-RA treatment in type 2 diabetes patients) Study Group
Nutr Metab Cardiovasc Dis. Pub. online 23 Mar 2024.
Leggi
Aldosterone synthase inhibitor (BI 690517) therapy for people with diabetes and albuminuric chronic kidney disease: A multicentre, randomized, double-blind, placebo-controlled, Phase I trial
Bornstein SR, de Zeeuw D, Heerspink HJL, et al.
Diabetes Obes Metab. Pub. online 18 Mar 2024.
Leggi
An automated insulin delivery system with automatic meal bolus based on a hand-gesturing algorithm
Roy A, Grosman B, Benedetti A, et al.
Diabetes Technol Ther. Pub. online 12 Mar 2024.
Leggi